The effect of vitamin e supplementation in liver enzymes, histology and metabolic biomarkers in adult patients with non-alcoholic fatty liver disease (NAFLD). a systematic review and meta-analysis

Does vitamin E help with improving non-alcoholic fatty liver disease?

“…A 2018 systematic review and meta-analysis of 17 randomized controlled trials (RCTs) and one quasirandomized trial (N51,355) from 11 countries evaluated the effectiveness of pelvic floor muscle therapy (PFMT) for women with SUI. 1 Patients were nonpregnant women with a mean age range of 45 to 77 years old without cancer, underlying neurological disorders, or significant cognitive impairment. Patients assigned to PFMT engaged in various programs of repeated voluntary pelvic floor muscle contractions, typically taught and supervised by healthcare professionals over four weeks to six months.…”

“…A 2020 meta-analysis of seven randomized controlled trials (RCTs) (N=465) evaluated the effect of vitamin E supplementation or placebo on biochemical and histological parameters in adults with nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH). 1 The duration of the RCTs ranged from 8 to 96 weeks. Patients received either 400- to 800-mg vitamin E daily or matched placebo.…”

“…A 2019 meta-analysis of nine RCTs (N=889) evaluated the effect of vitamin E therapy on improving outcomes in patients with NAFLD. 2 One RCT overlapped with the previous meta-analysis. The analysis included both adults and children with the mean ages ranging from 9.9 to 59 years, with 31% to 75% male.…”